Structure and design of Langya virus glycoprotein antigens

Zhaoqian Wang, Matthew McCallum, Lianying Yan, Cecily A. Gibson, William Sharkey, Young Jun Park, Ha V. Dang, Moushimi Amaya, Ashley Person, Christopher C. Broder, David Veesler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) glycoproteins which are the main targets of neutralizing antibodies. We show here that the LayV F and G glycoproteins promote membrane fusion with human, mouse, and hamster target cells using a different, yet unknown, receptor than Nipah virus (NiV) and Hendra virus (HeV) and that NiV- and HeV-elicited monoclonal and polyclonal antibodies do not cross-react with LayV F and G. We determined cryoelectron microscopy structures of LayV F, in the prefusion and postfusion states, and of LayV G, revealing their conformational landscape and distinct antigenicity relative to NiV and HeV. We computationally designed stabilized LayV G constructs and demonstrate the generalizability of an HNV F prefusion-stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and closely related HNVs.

Original languageEnglish
Article numbere2314990121
JournalProceedings of the National Academy of Sciences of the United States of America
Volume121
Issue number16
DOIs
StatePublished - 16 Apr 2024
Externally publishedYes

Keywords

  • CryoEM
  • Henipavirus
  • Langya virus
  • antibodies
  • vaccine design

Cite this